Each of the RSU grants vests ratably in equal installments on the first, second, and third anniversaries of the grant date, subject to the recipient's continued service with the Company through the ...

A trial for psilocybin therapy to treat depression is being opened to Vancouver Island applicants. Psilocybin is a psychedelic found naturally through more than 200 species of fungi commonly called ...

Ruby Jackson speaks to the psychiatrist researching the therapeutic potential of psychedelics ...

Harvard researchers have found that M. morganii may contribute to depression by producing an inflammatory molecule.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Shares of GH Research PLC GHRS have rallied 54.8% in a week after the company, on Feb. 3, 2025, announced that it has met the ...

As part of The Wistar Institute's Melanoma Research Center, the Villanueva lab pursues new ways to overcome the challenge of melanoma drug resistance. In this paper, the group took aim at melanomas ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .

Depression affects 280 million people worldwide. The mental illness has been proven to lead to changes in eating behavior. Researchers have discovered that although patients with depression generally ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...

In people with treatment-resistant depression, investigational inhalable mebufotenin yielded a 15.5-point placebo-adjusted ...